FRANKFURT, Dec 14 (Reuters) - German researchers have found that COVID-19 therapies developed by Eli Lilly (LLY.N), opens new tab and Regeneron (REGN.O), opens new tab lose most of their effectiveness ...

Since late last year, federal officials have been asking, practically begging people to get booster doses of the COVID-19 vaccine. But more than half of Americans have ignored the request even for a ...

An international research consortium, led by scientists at VIB and UGent, has developed a new platform that could change how antibody medicines are tested and brought to patients. The work, published ...

WEST PALM BEACH, Fla. — If you've been infected with COVID-19 or got the vaccine, you likely have antibodies. But what does that really tell you? Waking up every day in a pandemic for Leigh Ann David ...

Researchers developed a humanized mouse model that better predicts how antibody drugs interact with the immune system. The ...

Last week, Adagio Therapeutics raised $80 million in a series B financing to speed its COVID-19 antibody into development. This week, it provided some details about how its approach differs from the ...

ROCKVILLE, Md.--(BUSINESS WIRE)--20/20 GeneSystems, Inc., today announced that it has received its first allotment of the new Elecsys Anti-SARS-CoV-2 S lab-based blood test that quantitatively ...

Among them are the drive-thru site run by Test Iowa, sites at local Walgreens and Hy-Vee stores and at local health care providers. What type of tests are available? Providers in the metro offer ...

FRANKFURT (Reuters) - German researchers have found that COVID-19 therapies developed by Eli Lilly and Regeneron lose most of their effectiveness when exposed in laboratory tests to the Omicron ...